Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap)  (beta) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer) Overgo Probe Designer
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

Ontology Browser
Term:
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor (CHEBI:77108)
Annotations: Rat: (228) Mouse: (236) Human: (242) Chinchilla: (0) Bonobo: (0) Dog: (0) Squirrel: (0) Pig: (0)
Parent Terms Term With Siblings Child Terms
EC 1.1.1.1 (alcohol dehydrogenase) inhibitor +   
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor +   
An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of 15-hydroxyprostaglandin dehydrogenase (NAD(+)) (EC 1.1.1.141).
EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor +   
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor +   
EC 1.1.1.159 (7alpha-hydroxysteroid dehydrogenase) inhibitor +  
EC 1.1.1.170 [3beta-hydroxysteroid-4alpha-carboxylate 3-dehydrogenase (decarboxylating)] inhibitor +  
EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor +   
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor +   
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor +   
EC 1.1.1.205 (IMP dehydrogenase) inhibitor +   
EC 1.1.1.21 (aldehyde reductase) inhibitor +   
EC 1.1.1.210 [3beta(or 20alpha)-hydroxysteroid dehydrogenase] inhibitor +   
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor +   
EC 1.1.1.267 (1-deoxy-D-xylulose-5-phosphate reductoisomerase) inhibitor +  
EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor +   
EC 1.1.1.37 (malate dehydrogenase) inhibitor +  
EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor +  
EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor +   

Synonyms
Related Synonyms: (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitor ;   (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitors ;   (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprost-5,13-dienoate:NAD(+) 15-oxidoreductase inhibitor ;   (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprost-5,13-dienoate:NAD(+) 15-oxidoreductase inhibitors ;   11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitor ;   11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitors ;   15-OH-PGDH inhibitor ;   15-OH-PGDH inhibitors ;   15-hydroxyprostaglandin dehydrogenase (NAD(+)) (EC 1.1.1.141) inhibitors ;   15-hydroxyprostaglandin dehydrogenase (NAD(+)) inhibitor ;   15-hydroxyprostaglandin dehydrogenase (NAD(+)) inhibitors ;   15-hydroxyprostaglandin dehydrogenase inhibitor ;   15-hydroxyprostaglandin dehydrogenase inhibitors ;   15-hydroxyprostanoic dehydrogenase inhibitor ;   15-hydroxyprostanoic dehydrogenase inhibitors ;   EC 1.1.1.141 inhibitor ;   EC 1.1.1.141 inhibitors ;   NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase (type I) inhibitor ;   NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase (type I) inhibitors ;   NAD-specific 15-hydroxyprostaglandin dehydrogenase inhibitor ;   NAD-specific 15-hydroxyprostaglandin dehydrogenase inhibitors ;   PGDH inhibitor ;   PGDH inhibitors ;   prostaglandin dehydrogenase inhibitor ;   prostaglandin dehydrogenase inhibitors
Xrefs: PMID:21072165 ;   Wikipedia:15-hydroxyprostaglandin_dehydrogenase_(NAD%2B)

paths to the root